This study evaluated glycaemic outcomes across three hybrid AID systems in adults with type 1 diabetes (T1D).<h4>Methods</h4>This was a retrospective, observational, single-centre study and included adults with T1D who transitioned from multiple daily injections (MDI) or non-automated insulin pump therapy to hybrid AID. Here, INS is linked to type 1 diabetes mellitus.